Pneumocystis jirovecii pneumonia in a non-HIV immunocompromised patient presenting with bilateral pneumothoraces.

BMJ Case RepSep 22, 2026 (epub)

Neil Alden Yee Tan, Joel Marquez Santiaguel

✦ AI-curated · Sources linked

Case in brief

A non-HIV immunocompromised patient developed Pneumocystis jirovecii pneumonia (PJP) after prolonged corticosteroid therapy, initially presenting with dyspnoea and fever. Imaging revealed bilateral pneumothoraces alongside ground-glass opacities. Despite antimicrobial treatment and pleural drainage, the patient experienced complications including persistent air leak and ventilator-associated pneumonia, ultimately leading to death.

What made this case unusual

The case is notable for the occurrence of bilateral pneumothoraces as a rare and life-threatening complication of PJP in a non-HIV immunocompromised patient.

Diagnostic / clinical pearl

Clinicians should maintain a high index of suspicion for PJP in non-HIV immunocompromised patients, especially those on corticosteroids, as early recognition is crucial for management.

Why it matters

This case emphasizes the need for consideration of prophylaxis and prompt assessment for structural complications in high-risk patients to enhance clinical outcomes.

Source

Published in BMJ Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.